![]() |
| Novartis Vaccines and Diagnostics Inc. |
The North Carolina Biotechnology Center recognizes that coordinating statewide research assets and resources and developing a solid industry infrastructure can propel innovation and facilitate commercialization.
The Center of Innovation for Nanobiotechnology (COIN) is a non-profit organization dedicated to accelerating commercialization of nanobiotechnologies in North Carolina. COIN is strengthening the nanobiotechnology industry in North Carolina by:
COIN started with the cooperation and collaboration of three Piedmont Triad universities and the Piedmont Triad Partnership, a non-profit 12-county regional economic development corporation.
The Piedmont Triad was a logical birthplace for COIN. It is the home of the Joint School of Nanoscience and Nanoengineering, a two-campus collaboration between North Carolina Agricultural and Technical (A&T) State University and the University of North Carolina at Greensboro (UNCG). The Triad is also home to The Center of Nanotechnology and Molecular Materials at Wake Forest University.
In 2007, the NC Biotechnology Center awarded a $100,000 Phase I COI planning grant to these partners to allow for the development of a business plan for the future Center of Innovation for Nanobiotechnology. Following the submission of the business plan for review, the Center approved a $2.5 million Phase II COI grant that allowed the creation and launch of COIN.
Since its inception, the COIN consortium has expanded to include Duke University, North Carolina State University, the University of North Carolina at Chapel Hill and UNC-Charlotte. COIN operates across the state and supports nanobiotech advances around the world.
There are over 50 emerging nanotech companies and 35 emerging nanobiotech companies in North Carolina. Other nanotechnology-related facts about the state are: